141 related articles for article (PubMed ID: 2970203)
1. Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin.
Mertens C; Pintens H
Acta Psychiatr Scand; 1988 Jun; 77(6):683-8. PubMed ID: 2970203
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, multicentre study of paroxetine and mianserin in depression.
Mertens C; Pintens H
Acta Psychiatr Scand Suppl; 1989; 350():140. PubMed ID: 2530770
[No Abstract] [Full Text] [Related]
3. Mirtazapine compared with paroxetine in major depression.
Benkert O; Szegedi A; Kohnen R
J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
[TBL] [Abstract][Full Text] [Related]
4. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
Dunner DL; Cohn JB; Walshe T; Cohn CK; Feighner JP; Fieve RR; Halikas JP; Hartford JT; Hearst ED; Settle EC
J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
[TBL] [Abstract][Full Text] [Related]
5. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
Fabre LF
J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
[TBL] [Abstract][Full Text] [Related]
6. Sleep and paroxetine: a comparison with mianserin in elderly depressed patients.
Dorman T
Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():53-8. PubMed ID: 1431012
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
Kiev A
J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
[TBL] [Abstract][Full Text] [Related]
9. A placebo- and imipramine-controlled study of paroxetine.
Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
[TBL] [Abstract][Full Text] [Related]
10. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.
Szegedi A; Müller MJ; Anghelescu I; Klawe C; Kohnen R; Benkert O
J Clin Psychiatry; 2003 Apr; 64(4):413-20. PubMed ID: 12716243
[TBL] [Abstract][Full Text] [Related]
11. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients.
Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
Acta Psychiatr Scand Suppl; 1989; 350():117-23. PubMed ID: 2530761
[TBL] [Abstract][Full Text] [Related]
13. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
Feighner JP; Boyer WF
Acta Psychiatr Scand Suppl; 1989; 350():125-9. PubMed ID: 2530763
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
[TBL] [Abstract][Full Text] [Related]
15. A double-blind out-patient trial of indalpine vs mianserin.
Naylor GJ; Martin B
Br J Psychiatry; 1985 Sep; 147():306-9. PubMed ID: 3904886
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
Daléry J; Aubin V
Encephale; 2001; 27(1):71-81. PubMed ID: 11294041
[TBL] [Abstract][Full Text] [Related]
17. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
Feighner JP; Boyer WF
J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care.
Romeo R; Patel A; Knapp M; Thomas C
Int Clin Psychopharmacol; 2004 May; 19(3):125-34. PubMed ID: 15107654
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.
Claghorn JL
J Clin Psychiatry; 1992 Feb; 53 Suppl():33-5. PubMed ID: 1531821
[TBL] [Abstract][Full Text] [Related]
20. Paroxetine versus placebo: a double-blind comparison in depressed patients.
Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
